BSC, if possible, will utilize any commercially available anticoagulant per end-user specifications.

HUMAN WHOLE BLOOD UNSPUN (100)

100-03 Sodium Citrate

100-05 Sodium Fluoride

100-07 Potassium Oxalate

100-09 Sodium Fluoride/Potassium Oxalate

100-11 Heparin (Sodium)

100-13 Heparin (Lithium)

100-15 ACD

100-17 CPD

100-19 CPDA-1

100-21 EDTA (Sodium)

100-23 EDTA (Potassium)

100-25 EDTA (Sodium Fluoride)

100-29 Phosphoric Acid

HUMAN SERUM FROM WHOLE BLOOD (115)

115-00 Anticoagulant Free

HUMAN PLASMA FROM WHOLE BLOOD (130)

130-03 Sodium Citrate

130-05 Sodium Fluoride

130-07 Potassium Oxalate

130-09 Sodium Fluoride/Potassium Oxalate

130-11 Heparin (Sodium)

130-13 Heparin (Lithium)

130-15 ACD

130-17 CPD

130-19 CPDA-1

130-21 EDTA (Sodium)

130-23 EDTA (Potassium)

130-25 EDTA (Sodium Fluoride)

SOURCE PLASMA (150)

150-03 Sodium Citrate

150-11 Heparin (Sodium)

150-15 ACD

PLATELET RICH PLASMA (190)

190-03 Sodium Citrate

190-15 ACD

190-17 CPD

190-19 CPDA-1

HUMAN PLATELET CONCENTRATES (201)

201-15 ACD

HUMAN LEUKOCYTES - PMN ENRICHED (210)

210-27 Trisodium Citrate/Hespan

HUMAN LEUKOCYTES (211)

211-15 ACD

HUMAN LEUKOCYTES - MNC ENRICHED (213)

213-15 ACD

PACKED RED BLOOD CELLS (235)

235-03 Sodium Citrate

235-05 Sodium Fluoride

235-07 Potassium Oxalate

235-09 Sodium Fluoride/Potassium Oxalate

235-11 Heparin (Sodium)

235-13 Heparin (Lithium)

235-15 ACD

235-17 CPD

235-19 CPDA-1

235-21 EDTA (Sodium)

235-23 EDTA (Potassium)

235-25 EDTA (Sodium Fluoride)

To The Product Information Page

Copyright ©2008 Biological Specialty Corporation